Claudia Zuany Amorim

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. ncbi Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells
    Claudia Zuany-Amorim
    Novartis Horsham Research Centre, Novartis Pharmaceutical Ltd Wimblehurst Road, Horsham, UK
    Nat Med 8:625-9. 2002
  2. ncbi Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation
    Claudia Zuany-Amorim
    Novartis Horsham Research Center, Novartis Pharmaceutical Ltd, Horsham, United Kingdom
    J Immunol 169:1492-9. 2002
  3. ncbi Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720
    Elzbieta Sawicka
    Novartis Horsham Research Centre, Horsham, U K
    J Immunol 171:6206-14. 2003
  4. ncbi Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases
    Claudia Zuany-Amorim
    Novartis Horsham Research Centre, Novartis Pharmaceutical Ltd, Horsham, UK
    Int Arch Allergy Immunol 133:154-63. 2004
  5. ncbi Toll-like receptors as potential therapeutic targets for multiple diseases
    Claudia Zuany-Amorim
    Novartis Horsham Research Centre, Novartis Pharmaceutical Ltd, Wimblehurst Road, Horsham, West Sussex RH12 5AB, UK
    Nat Rev Drug Discov 1:797-807. 2002
  6. ncbi Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke
    Paulo Castro
    Departamento de Bioquimica Medica, ICB, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941 590, Brazil
    Eur J Pharmacol 498:279-86. 2004

Collaborators

  • Alexandre Trifilieff
  • V Brinkmann
  • Elzbieta Sawicka
  • C Walker
  • Claudia Zuany-Amorim
  • Corinne Manlius
  • Paulo Castro
  • Graham Pay
  • Gareth Bowen
  • Graham Rook
  • Laura R Brunet
  • Luis Cristovao Porto
  • Larissa Cardilo-Reis
  • Vera Lúcia Gonçalves Koatz
  • Iben Dalum
  • Søren Mouritsen
  • Martin R Jensen
  • Samuel Valença
  • Anand Gautam
  • Alexandre Legora-Machado
  • John Hastewell
  • David M Kemeny
  • Alain Le Moine

Detail Information

Publications6

  1. ncbi Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells
    Claudia Zuany-Amorim
    Novartis Horsham Research Centre, Novartis Pharmaceutical Ltd Wimblehurst Road, Horsham, UK
    Nat Med 8:625-9. 2002
    ..Thus, regulatory T cells generated by mycobacteria treatment may have an essential role in restoring the balance of the immune system to prevent and treat allergic diseases...
  2. ncbi Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation
    Claudia Zuany-Amorim
    Novartis Horsham Research Center, Novartis Pharmaceutical Ltd, Horsham, United Kingdom
    J Immunol 169:1492-9. 2002
    ....
  3. ncbi Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720
    Elzbieta Sawicka
    Novartis Horsham Research Centre, Horsham, U K
    J Immunol 171:6206-14. 2003
    ....
  4. ncbi Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases
    Claudia Zuany-Amorim
    Novartis Horsham Research Centre, Novartis Pharmaceutical Ltd, Horsham, UK
    Int Arch Allergy Immunol 133:154-63. 2004
    ..The present work describes a simple and effective method to induce the production of therapeutic anti-cytokine autoantibodies by active immunization against a modified endogenous cytokine...
  5. ncbi Toll-like receptors as potential therapeutic targets for multiple diseases
    Claudia Zuany-Amorim
    Novartis Horsham Research Centre, Novartis Pharmaceutical Ltd, Wimblehurst Road, Horsham, West Sussex RH12 5AB, UK
    Nat Rev Drug Discov 1:797-807. 2002
    ..In this review, we discuss the current and future use of TLR agonists or antagonists in chronic inflammatory diseases and highlight potential problems that are associated with such approaches...
  6. ncbi Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke
    Paulo Castro
    Departamento de Bioquimica Medica, ICB, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941 590, Brazil
    Eur J Pharmacol 498:279-86. 2004
    ....